Mustang Bio and Nationwide Children’s Hospital Enter into Exclusive Worldwide License Agreement for Oncolytic Virus (C134) to Treat Glioblastoma Multiforme

NEXT STORY
Cytokinetics Announces Initiation of Phase 1 Clinical Study of AMG 594, a Cardiac Troponin Activator
PREV STORY
Antibiotics Market Expected to Garner $50.37 Bn by 2025 at 2.1% CAGR, Says AMR
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Arch Biopartners Receives Approval from Turkish Ministry of Health to Proceed with Phase II Trial for LSALT Peptide; Begins Screening Patients in Florida

author_avatar
NASDAQ Market News

Radius Health Appoints Pharmaceutical Executive Jose Carmona as Chief Financial Officer

WALTHAM, Mass., May 15, 2017 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the ...

author_avatar
NASDAQ Market News

Heather R. Hayes & Associates Is Proud To Announce That Founder, Heather Hayes, Is Joining A&E Network’s EMMY® Award-Winning Docuseries ‘Intervention’ For A Special New Season

Cumming, GA , Dec. 20, 2017 (GLOBE NEWSWIRE) -- In an official corporate announcement ...

author_avatar
NASDAQ Market News